HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pablo Lapuerta Selected Research

Carcinoid Tumor (Carcinoid)

1/2022Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.
3/2021Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome.
1/2020Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study.
1/2020Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency: An Observational Patient-Reported Outcomes Study.
1/2020Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome.
11/2019TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World.
10/2019Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome.
1/2019Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome.
1/2019Burden of Carcinoid Heart Disease in Patients With Carcinoid Syndrome Initiating Somatostatin Analogues.
12/2018Relationship Between Symptoms and Health-related Quality-of-life Benefits in Patients With Carcinoid Syndrome: Post Hoc Analyses From TELESTAR.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pablo Lapuerta Research Topics

Disease

20Carcinoid Tumor (Carcinoid)
01/2022 - 10/2014
14Diarrhea
01/2022 - 11/2010
12Hypertension (High Blood Pressure)
10/2018 - 02/2002
11Type 2 Diabetes Mellitus (MODY)
12/2021 - 08/2004
8Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 07/2015
7Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2020 - 10/2014
6Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
01/2021 - 12/2017
6Heart Failure
01/2021 - 06/2002
5Body Weight (Weight, Body)
12/2021 - 07/2013
5Hypoglycemia (Reactive Hypoglycemia)
01/2021 - 07/2015
3Infections
01/2021 - 03/2015
3Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 11/2003
3Weight Loss (Weight Reduction)
09/2018 - 07/2015
3Stroke (Strokes)
04/2016 - 11/2003
3Chronic Kidney Failure (Chronic Renal Failure)
11/2006 - 08/2004
2Chronic Renal Insufficiency
12/2021 - 01/2021
2Weight Gain
11/2020 - 01/2018
2Neoplasms (Cancer)
01/2020 - 01/2020
2Nausea
01/2018 - 01/2017
2Flushing
01/2018 - 04/2015
2Hemorrhage
09/2016 - 11/2010
2Coronary Artery Disease (Coronary Atherosclerosis)
04/2016 - 11/2010
2Alzheimer Disease (Alzheimer's Disease)
01/2011 - 01/2002
2Diabetic Nephropathies (Diabetic Nephropathy)
11/2006 - 08/2004
1Hypotension (Low Blood Pressure)
01/2021
1Albuminuria
01/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2021
1Hyperglycemia
11/2019
1Carcinoid Heart Disease
01/2019
1Chest Pain (Chest Pains)
10/2018
1Abdominal Pain (Pain, Abdominal)
01/2018
1Acute Coronary Syndrome
09/2016
1Hyperlipidemias (Hyperlipidemia)
04/2016
1Peripheral Arterial Disease
04/2016
1Heart Valve Diseases (Valvular Heart Disease)
04/2015
1Urinary Tract Infections (Urinary Tract Infection)
03/2015
1Obesity
12/2007
1Diabetes Mellitus
08/2005
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2003
1Coronary Disease (Coronary Heart Disease)
01/2003

Drug/Important Bio-Agent (IBA)

15telotristat ethylIBA
01/2022 - 01/2017
15(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA
12/2021 - 07/2013
11Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022 - 01/2017
8IrbesartanFDA LinkGeneric
10/2009 - 08/2004
7Insulin (Novolin)FDA Link
01/2021 - 07/2015
7Serotonin (5 Hydroxytryptamine)IBA
01/2020 - 10/2014
7Tryptophan HydroxylaseIBA
11/2019 - 01/2016
5Glucose (Dextrose)FDA LinkGeneric
12/2021 - 07/2013
5Sodium-Glucose Transport ProteinsIBA
01/2021 - 03/2015
5Hydrochlorothiazide (Esidrix)FDA LinkGeneric
10/2009 - 12/2006
5Antihypertensive Agents (Antihypertensives)IBA
12/2007 - 01/2003
4telotristatIBA
01/2018 - 10/2014
3Sodium-Glucose Transporter 2 InhibitorsIBA
01/2021 - 07/2015
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2021 - 07/2013
3Octreotide (Sandostatin)FDA LinkGeneric
10/2018 - 10/2014
3CreatinineIBA
11/2006 - 08/2004
2SodiumIBA
12/2021 - 01/2015
2Sodium-Glucose Transporter 1IBA
09/2018 - 09/2018
2Pharmaceutical PreparationsIBA
11/2017 - 06/2002
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
09/2016 - 04/2016
2Omeprazole (Prilosec)FDA LinkGeneric
09/2016 - 11/2010
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2016 - 11/2010
2Metformin (Glucophage)FDA LinkGeneric
03/2015 - 07/2013
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
08/2005 - 08/2004
2omapatrilatIBA
08/2004 - 06/2002
1Tryptophan (L-Tryptophan)FDA Link
01/2020
1KetonesIBA
11/2019
1Cholinergic Antagonists (Anticholinergics)IBA
01/2019
1AtropineFDA LinkGeneric
01/2019
1DiphenoxylateFDA LinkGeneric
01/2019
1Loperamide (Imodium)FDA LinkGeneric
01/2019
1Hydroxyindoleacetic AcidIBA
01/2018
1Blood Glucose (Blood Sugar)IBA
12/2017
1Acetic Acid (Vinegar)FDA LinkGeneric
01/2017
15-hydroxyindoleIBA
01/2017
1TransferasesIBA
01/2017
1AcidsIBA
10/2014
1Biomarkers (Surrogate Marker)IBA
01/2011
1Donepezil (Aricept)FDA LinkGeneric
01/2011
1Clopidogrel (Plavix)FDA Link
11/2010
1Angiotensin Receptor AntagonistsIBA
05/2009
1ThiazidesIBA
05/2009
1DiureticsIBA
08/2005
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
08/2005
1Cardiac GlycosidesIBA
08/2005
1Indicators and Reagents (Reagents)IBA
08/2005
1Spironolactone (Aldactone)FDA LinkGeneric
08/2005
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
08/2004
1Angiotensin II Type 2 Receptor BlockersIBA
08/2004
11,4-dihydropyridine (dihydropyridine)IBA
08/2004
1cyclo(Arg-Pro) (CI 4)IBA
05/2004
1Vasopeptidase InhibitorsIBA
06/2002
1Lisinopril (Prinivil)FDA LinkGeneric
06/2002

Therapy/Procedure

21Therapeutics
01/2021 - 02/2002
3Glycemic Control
12/2017 - 07/2013
2Percutaneous Coronary Intervention
09/2016 - 04/2016
1Injections
12/2017
1Drug Tapering
07/2015
1Drug Therapy (Chemotherapy)
05/2004
1Ambulatory Care (Outpatient Care)
11/2003